With the popularity of healthcare apps linked to wearable devices exploding in Korea, a government-affiliated medical research institute in the country is recommending authorities establish guidelines to ensure the apps are accurate, reliable, and effective.
The Korea Health Industry Development Institute (KHIDI) announced this fall it had drafted suggested guidelines on the more than 300,000 such apps it estimates are in circulation in the country. The guidelines include recommendations that the development of such apps be based on clinical evidence and systematic trials, and that their accuracy be verified by independent arbiters.
The draft guidelines are modeled in part on similar verification systems already in use in the United States and many European countries.
Written by: Ames Gross – President and Founder, Pacific Bridge Medical (PBM)
Mr. Gross founded PBM in 1988 and has helped hundreds of medical companies with regulatory and business development issues in Asia. He is recognized nationally and internationally as a leader in the Asian medical markets. Mr. Gross has a BA degree, Phi Beta Kappa, from the University of Pennsylvania and an MBA from Columbia University.
Source used in the article: https://iclg.com/practice-areas/digital-health-laws-and-regulations/korea